Resumo
Background: The nonsteroidal anti-inflammatory drugs (NSAIDs) exert their analgesic effect through peripheral inhibition of prostaglandin synthesis and a variety of other peripheral and central mechanisms. However, NSAIDs are associated with some adverse effects, mainly related to the gastrointestinal, renal, and hepatic systems, highlighting the need for research to develop safer drugs. Therefore, the aim of this study was to evaluate the efficacy of preoperative oral administration of carprofen or grapiprant in female cats submitted to elective ovariohysterectomy on the quality of perioperative analgesia and the need for hypnotic and analgesic drugs. Materials, Methods & Results: Thirty-three adult female cats were selected, without defined breed and healthy based on physical examination, routine laboratory analyses (complete blood count, total protein, Heinz body investigation and serum quantification of alanine transaminase [ALT], aspartate transaminase [AST], gamma glutamyl transpeptidase [GGT], alkaline phosphatase [ALP], urea, frutosamine, and glucose) and negative tests for feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV). After 3 days of adaptation, they were submitted to ovariohysterectomy by celiotomy and randomly allocated into 2 groups according to the preoperative drug used: GCAR [carprofen - 4 mg/kg, VO, 2 h before surgery; n = 11] and GGRA (grapiprant - 2 mg/kg IV, 2 h before surgery; n = 21]. The cats were pre-medicated with acepromazine 0.05 mg/ kg IV and later submitted to general anesthesia with propofol intravenously. Anesthesia was maintained with isoflurane in 100% oxygen. After anesthetic induction, a continuous infusion of remifentanil at a rate of 10 µg/kg/h was initiated. During the transanesthetic period, the parameters of heart rate; respiratory rate; systolic, mean, and diastolic arterial pressure using the oscillometric method; electrocardiogram; rectal temperature; partial pressure of CO2 at the end of expiration: and partial saturation of O2 in hemoglobin were continuously monitored. The evaluation of nociception was based on the changes in the aforementioned physiological parameters. The rate of remifentanil used did not change over time with the use of carprofen. However, animals that received grapiprant required a lower remifentanil dose at 20, 25, and 30 min during the procedure. The female cats that received carprofen showed an increase in mean heart rate at 30 min compared to that at 20 and 25 min. In the Grapiprant group, the heart rate at 35 min was higher only than that observed at 25 min. Discussion: The remifentanil rate did not differ between the groups, even between the times for GCAR. However, the remifentanil rate was lower from 20 min of the procedure for GGRA. This decrease may be related to a decrease in the need for anesthetics and analgesics by decreasing temperature, which causes decreases in metabolism and surgical stimulation. The increase in systolic, mean, diastolic, and heart rate arterial pressure parameters observed in both treatments after 15 min of anesthesia is related to the nociceptive stimulus resulting from traction and ligation of the ovarian pedicles and maneuvers for exteriorization of the uterus. These are considered the moments of greater surgical stimulus during ovariohysterectomy, evidenced by the greater release of cortisol and increase in physiological parameters. The results of this study show that the administration of carprofen or grapiprant was clinically similar when used preemptively for perioperative analgesia in cats submitted to elective ovariohysterectomy.
Assuntos
Animais , Feminino , Gatos , Ovariectomia/veterinária , Anti-Inflamatórios não Esteroides/administração & dosagem , Histerectomia/veterinária , Carbazóis/análise , Dinoprostona , NociceptividadeResumo
Background: Prostaglandin F2 alpha (PGF2 α) binds to the specific receptor (PTGFR) on the corpus luteum (CL) in mammals, inducing regression of the CL structure (luteolysis) and initiating a new cycle. While PGF2 α is effective only on mature CL, the immature CL structure (early luteal phase) resists PGF2 α. In this study, sildenafil citrate, which is used to increase blood flow in the genital organs for treating specific pregnancy issues in women, was administered during the early luteal phase in a rabbit model to test the hypothesis of enhancing blood flow to the CL, thereby promoting earlier maturation and enabling a response to PGF2 α. Materials, Methods & Results: The study was conducted in 2 sub-studies: clinical and molecular. A large number of rabbits were initially included in the sub-studies to ensure a sufficient number of pseudo-pregnant rabbits. Ovulation in rabbits was induced with buserelin acetate and was considered as day 0 of the study. The sub-studies were continued with rabbits whose pseudo-pregnancies were confirmed according to progesterone (P4 ) results. As a result, the studies were continued with a total of 41 pseudo-pregnant New Zealand female rabbits, 21 of which were included in the clinical sub-study and 20 in the molecular sub-study. In both sub-studies, on day 3 of the luteal period, rabbits in the treatment group received 5 mg/kg sildenafil citrate and all rabbits received a single dose of exogenous PGF2 α on day 4 to induce luteolysis. In the clinical sub-study, echotexture and intraovarian blood flow changes in the ovaries were determined by ultrasonography (USG) examination. In the molecular sub-study, the expression changes of Hypoxia Inducible Factor 1 Alpha (HIF1A) and Vascular Endothelial Growth Factor (VEGF) related to angiogenesis, Steroidogenic Acute Regulatory Protein (StAR) related to P4 metabolism, Prostaglandin-Endoperoxide Synthase 2 (PTGS2) related to prostaglandin (PG) mechanism and 15-Hydroxyprostaglandin Dehydrogenase (HPGD) genes at mRNA level were determined using Real Time Polymerase Chain Reaction (RT-PCR) in CL tissues obtained with ovariohysterectomy (OVH) at 1 and 12 h after PGF2 α injection. In addition, blood samples were collected for determine P4 levels from all rabbits. In the clinical sub-study; there was no difference between the groups in mean gray values (MGV), whereas there was a significant decrease in both pulsatile index (PI) and resistance index (RI) values at 40 min after PGF2 α injection (P < 0.05). In the molecular sub-study, it was determined that sildenafil citrate had no significant effect (P > 0.05) on the expression levels 1 and 12 h after PGF2 α injection. According to the results of the molecular sub-study, no significant effect of sildenafil citrate on the mRNA expression levels in the investigated genes was detected (P > 0.05). However, within each group, differences were found according to OVH time after PGF2 α injection. It was observed that PTGS2 and HPGD mRNA expressions decreased at the 12th h compared to the 1st h, while HIF1A expression increased (P < 0.05). Discussion: According to the results obtained from clinical and molecular sub-studies, it was determined that a single dose of sildenafil citrate (5 mg/kg) applied on the 3rd day of the luteal period did not contribute to the maturation process of the CL, did not increase blood flow, and was insufficient to break the resistance of the CL against PGF2 α applied on the 4th day of the luteal period. However, a significant decrease in the PI value at the 40th min after PGF2 α injection suggests that sildenafil citrate has a supportive effect, and that this decrease is also seen in the RI value, suggesting that its effect is insufficient against the vasoconstrictive effect of PGF2 α.
Assuntos
Animais , Feminino , Coelhos , Dinoprosta/administração & dosagem , Corpo Lúteo/crescimento & desenvolvimento , Citrato de Sildenafila/administração & dosagem , Luteolíticos/análiseResumo
Vacas de alta produção de leite estão mais sujeitas a desequilíbrios metabólicos pós-parto, influenciando na performance reprodutiva subsequente. Alterações relacionadas a funcionalidade do ovário podem desencadear desequilíbrios hormonais e desordens reprodutivas, como a formação de cistos ovarianos, os quais podem interferir no processo de ovulação e impactar substancialmente na eficiência reprodutiva. Neste estudo de caso em específico, sete vacas leiteiras foram diagnosticadas com a presença de cistos foliculares ovarianos. Foram submetidas a terapia hormonal envolvendo o uso de análogos de Hormônio Liberador de Gonadotrofinas (GnRH) e prostaglandina-F2a (PGF-2a), a qual apresentou resultados satisfatórios. A abordagem terapêutica hormonal tem sido amplamente utilizada devido à sua efetividade na resolução dos cistos ováricos e melhoria da função reprodutiva. É fundamental que o médico veterinário tenha conhecimento clínico sobre a abordagem adequada de cistos ovarianos, a fim de proporcionar saúde e bem-estar aos animais, garantindo bons índices em produção de leite e desempenho reprodutivo.
High milk production cows are more likely to postpartum metabolic imbalances, which may influence subsequent reproductive performance. Changes in ovarian functionality can trigger hormonal alterations and reproductive disorders, such as the formation of ovarian cysts, which can interfere with the ovulation process and substantially impact reproductive efficiency. In this specific case study, seven dairy cows were diagnosed with the presence of ovarian follicular cysts. They were submitted to hormonal therapy involving the use of Gonadotropin-Releasing Hormone (GnRH) and prostaglandin F2a (PGF-2a) analogs, which presented satisfactory results. Hormonal therapeutic approaches have been widely employed due to their effectiveness in resolving ovarian cysts and improving reproductive function. It is essential for the veterinarian to have clinical knowledge about the appropriate management of ovarian cysts in order to provide the health and welfare of the animals, ensuring suitable rates in milk production and reproductive performance.
Las vacas de alta producción de leche tienen mayor probabilidad de desequilibrios metabólicos posparto, lo cual puede influir en el rendimiento reproductivo posterior. Los cambios en la funcionalidad ovárica pueden desencadenar alteraciones hormonales y trastornos reproductivos, como la formación de quistes ováricos, que pueden interferir en el proceso de ovulación y afectar sustancialmente la eficiencia reproductiva. En este estudio de caso específico, se diagnosticó la presencia de quistes foliculares ováricos en siete vacas lecheras. Se sometieron a terapia hormonal que incluyó el uso de análogos de Hormona Liberadora de Gonadotropinas (GnRH) y prostaglandina F2α (PGF-2a), lo cual arrojó resultados satisfactorios. Los enfoques terapéuticos hormonales se han utilizado ampliamente debido a su efectividad en la resolución de quistes ováricos y la mejora de la función reproductiva. Es fundamental que el médico veterinario tenga conocimiento clínico sobre el manejo adecuado de los quistes ováricos para garantizar la salud y el bienestar de los animales, asegurando adecuadas tasas de producción de leche y rendimiento reproductivo.
Assuntos
Animais , Feminino , Bovinos , Cisto Folicular/terapia , Cisto Folicular/veterinária , Dinoprosta/administração & dosagem , Hormônio Liberador de Gonadotropina/administração & dosagem , Doenças do Sistema Endócrino/veterináriaResumo
Background: Multilobular tumor of bone (MTB) is an unusual neoplasm with variable biologic behavior which originates primarily in bone tissues. Radiographs computed tomography (CT), and magnetic resonance imaging (MRI) are useful in diagnoses and surgical planning. Tumor removal with wide surgical margins is the treatment of choice. Immunohistochemistry has been shown as an important tool in veterinary oncology to define therapeutic and prognostic decisions. The goal of this study was to report 2 distinct cases of multilobular tumor of bone, their Cox-2 and Mib-1 immunohistochemical profile and its impact on overall survival. Case: Two bitches were presented at the Oncology Department of the Veterinary Hospital in the Veterinary School of Universidade Federal de Minas Gerais (UFMG). Both had a history of a progressive, painless, circumscribed, and firm facial mass. The 1st patient was a 8-year-old intact bitch mixed breed, weighing 50 kg, that presented a fast growing right infraorbital 3-cm mass, causing eye displacement. The 2nd patient was a 7-year-old spayed bitch Labrador retriever, weighing 28 kg, that presented a left temporal 8-cm mass. Neurologic examination of both bitches was normal. Skin over the nodules was strained, but with no ulceration. Radiographic exams of the head revealed lytic and proliferative bone reaction, with loss of cortical definition in both cases. These alterations were seen on the left zygomatic arch of the retrobulbar region, involving part of the mandible and of the nasal sinus lateral frontal bone in 1st patient, and on the right temporal process of the zygomatic bone in 2nd patient. The last one, also showed a granular solid mass with little contact with skull bones. Complete blood count, biochemistry profile, electrocardiogram, and 3-view thoracic radiographs were performed. Results were within normal ranges for the species and no signs of metastasis was seen on the radiographs. Location, size, and density of the mass, adjacent tissue compression, absence of cranial invasion, and lymph node size were rigorously evaluated with CT, allowing an individualized surgical planning to achieve complete mass removal and maintenance of the function of adjacent structures. Both animals were submitted to surgery. Both tumors were fixed on 10% neutral buffered formalin and sent to the Animal Pathology Department of UFMG for histopathological examination and margin assessment. Both tumors were diagnosed as grade I MTB. Tumor immunohistochemistry was performed to identify prognostic factors that could be used to better define therapeutic treatments and to try to clarify the discrepancy in disease progression between both tumors. The 1st patient expressed 20% of Mib-1 and was considered score 2 of Cox-2. The 2nd one expressed 5% of Mib-1 and was considered score 1 of Cox-2. Considering the diagnoses and histological characteristics of the tumors, it was decided for clinical follow-up of patients without additional therapeutic complementation. Even considering incomplete surgical margins in 2nd patient, adjuvant chemotherapy was not performed, due to low mitotic index and low histological grade. The 1st patient had an overall survival of 240 days, and death was due to recurrence and disease progression; and the 2nd did not show recurrence nor metastasis after 1200 days. Discussion: Proper and individualized surgical planning and histopathological evaluation are extremely important to guide treatment decisions. However, immunohistochemistry can be important in MTB cases, to help define which patients should be submitted to surgery alone and which patients could be benefited from adjuvant chemotherapy.
Assuntos
Animais , Feminino , Cães , Neoplasias de Tecido Ósseo/veterinária , Antígeno Ki-67/análise , Ciclo-Oxigenase 2/análise , Imuno-Histoquímica/veterináriaResumo
ABSTRACT: Treatment with prostaglandin F2α (PGF) induces ovulation and increases conception rates in cows, while improving embryo production in buffalos. However, its effect on superovulated cows is unknown. This study verified whether single PGF administration concurrent with artificial insemination (AI) improves fertilization and embryo production rates in superovulated cows. In each replicate, embryo donor cows were equally allocated to two groups: the untreated control and PGF groups. The latter of which received 482 µg of cloprostenol concurrent with the first AI. Each cow (n = 35) was subjected to two superovulations (SOV) in a crossover design (total = 70 embryo collections). In the control and PGF groups, respectively, the observed responses were [median (95% CI)]: 12 (10-18) and 15 (12-18) total structures, 9 (7-11) and 7 (6-10) viable embryos, 1 (0-1) and 1 (1-3) degenerated embryos, and 1 (0-3) and 2 (0-5) oocytes (P > 0.05). In conclusion, single PGF treatment concurrent with the first AI did not affect embryo production in superovulated cows.
RESUMO: A prostaglandina F2α (PGF) pode induzir a ovulação e melhorar tanto a concepção em vacas, como a produção de embriões em búfalas, mas o efeito em vacas superovuladas é desconhecido. Esse estudo teve como objetivo verificar se a administração de uma dose de PGF na inseminação artificial (IA) após a superovulação (SOV) melhora as taxas de fecundação e produção embrionária em vacas. Em cada replicação, vacas doadoras de embriões foram equilibradamente alocadas em dois grupos: controle, não tratado, ou PGF, que recebeu 482 µg de cloprostenol no momento da primeira IA. Cada doadora (n = 35) foi submetida a duas SOV em um delineamento crossover (total = 70 coletas de embriões). Nos grupos controle e PGF, respectivamente, foram observados [medianas (IC 95%)]: 12 (10-18) e 15 (12-18) estruturas totais; 9 (7-11) e 7 (6-10) embriões viáveis; 1 (0-1) e 1 (1-3) embriões degenerados; e 1 (0-3) e 2 (0-5) ovócitos (P > 0,05). Conclui-se que uma única administração de PGF no momento da primeira IA não afeta a produção embrionária de vacas superovuladas.
Resumo
Treatment with prostaglandin F2α (PGF) induces ovulation and increases conception rates in cows, while improving embryo production in buffalos. However, its effect on superovulated cows is unknown. This study verified whether single PGF administration concurrent with artificial insemination (AI) improves fertilization and embryo production rates in superovulated cows. In each replicate, embryo donor cows were equally allocated to two groups: the untreated control and PGF groups. The latter of which received 482 µg of cloprostenol concurrent with the first AI. Each cow (n = 35) was subjected to two superovulations (SOV) in a crossover design (total = 70 embryo collections). In the control and PGF groups, respectively, the observed responses were [median (95% CI)]: 12 (10-18) and 15 (12-18) total structures, 9 (7-11) and 7 (6-10) viable embryos, 1 (0-1) and 1 (1-3) degenerated embryos, and 1 (0-3) and 2 (0-5) oocytes (P > 0.05). In conclusion, single PGF treatment concurrent with the first AI did not affect embryo production in superovulated cows.
A prostaglandina F2α (PGF) pode induzir a ovulação e melhorar tanto a concepção em vacas, como a produção de embriões em búfalas, mas o efeito em vacas superovuladas é desconhecido. Esse estudo teve como objetivo verificar se a administração de uma dose de PGF na inseminação artificial (IA) após a superovulação (SOV) melhora as taxas de fecundação e produção embrionária em vacas. Em cada replicação, vacas doadoras de embriões foram equilibradamente alocadas em dois grupos: controle, não tratado, ou PGF, que recebeu 482 µg de cloprostenol no momento da primeira IA. Cada doadora (n = 35) foi submetida a duas SOV em um delineamento crossover (total = 70 coletas de embriões). Nos grupos controle e PGF, respectivamente, foram observados [medianas (IC 95%)]: 12 (10-18) e 15 (12-18) estruturas totais; 9 (7-11) e 7 (6-10) embriões viáveis; 1 (0-1) e 1 (1-3) embriões degenerados; e 1 (0-3) e 2 (0-5) ovócitos (P > 0,05). Conclui-se que uma única administração de PGF no momento da primeira IA não afeta a produção embrionária de vacas superovuladas.
Assuntos
Animais , Bovinos , Inseminação Artificial/veterinária , Dinoprosta/administração & dosagem , Transferência Embrionária/veterinária , Estruturas Embrionárias/efeitos dos fármacos , FertilizaçãoResumo
Nos últimos anos, observou-se um aumento no tamanho do rebanho ovino no país, indicando uma retomada na ovinocultura. Para melhorar a eficiência reprodutiva desses animais, a utilização de biotécnicas tem se mostrado uma ferramenta importante. Dentre essas biotécnicas, destacam-se os protocolos de sincronização do ciclo estral, os quais frequentemente utilizam progesterona associada a gonadotrofinas ou análogos da prostaglandina em duas aplicações. Este artigo tem como objetivo revisar os protocolos de sincronização utilizados em ovinos e apresentar atualizações relevantes sobre os mesmos.(AU)
In recent years, there has been an increase in the size of the sheep herd in the country, indicating a recovery in sheep farming. To improve the reproductive efficiency of these animals, the use of biotechniques has been shown to be an important tool. Among these biotechniques, estrous cycle synchronization protocols stand out, which frequently use progesterone associated with gonadotropins or prostaglandin analogues in two applications. This article aims to review the synchronization protocols used in sheep and present relevant updates about them.(AU)
Assuntos
Animais , Feminino , Ovinos/fisiologia , Ciclo Estral/fisiologia , Sincronização do Estro/métodos , Fenômenos Reprodutivos FisiológicosResumo
A resistência aos antimicrobianos representa uma ameaça sanitária global crescente, que deve ser abordada com urgência na saúde pública, na produção animal, agrícola e no meio ambiente. Essa circunstância põe em risco a eficiência do tratamento e diminui a eficácia contra infecções causadas pelos mais diversos agentes etiológicos, resultando em enfermidades mais prolongadas afetando diretamente os índices de fertilidade. Dessa forma, o objetivo dessa revisão foi abordar diferentes formas terapêuticas para sub/infertilidade em equinos, com o intuito de minimizar os problemas acarretados pelo uso indiscriminado de fármacos, relatando novas terapias alternativas, tais como ozonioterapia, plasma rico em plaquetas, uso de prostaglandina E1 e imunomoduladores na tentativa de solucionar velhos problemas.(AU)
Antimicrobial resistance represents a growing global health threat that must be urgently addressed in public health, animal production, agriculture and the environment. This circumstance jeopardizes the efficiency of the treatment and decreases the effectiveness against infections caused by the most diverse etiological agents, resulting in more prolonged illnesses, directly affecting fertility rates. Thus, the objective of this review was to address different therapeutic forms for sub/infertility in horses, with the aim of minimizing the problems caused by the indiscriminate use of drugs, reporting new alternative therapies, such as ozone therapy, platelet-rich plasma, use of prostaglandin E1 and immunomodulators in an attempt to solve old problems.(AU)
Assuntos
Animais , Usos Terapêuticos , Cavalos/imunologia , Anti-Infecciosos/uso terapêutico , Misoprostol , Plasma Rico em Plaquetas , Imunomodulação , Ozonioterapia , Fitoterapia/tendênciasResumo
Este texto discute as estratégias farmacológicas para a manipulação do ciclo estral de fêmeas taurinas de corte, com foco na inseminação artificial em tempo fixo (IATF). Os zebuínos, rebanho predominante no Brasil, apresentam características de ciclo estral diferentes das raças taurinas, o que justifica a busca por estratégias hormonais adaptadas para o controle do ciclo estral nas subespécies. O estradiol combinado com a progesterona (P4) e prostaglandina F2 alfa (PGF) é o esquema hormonal mais comumente utilizado para a manipulação do ciclo estral em protocolos de IATF. Porém, o uso de GnRH combinado ou em substituição aos ésteres de estradiol vem sendo considerado. Coletivamente, os dados do nosso grupo reforçam a necessidade de customizar as abordagens para o controle do ciclo estral de acordo com a composição genética das fêmeas bovinas.(AU)
This text discusses pharmacological strategies to manipulate the estrous cycle of taurine and synthetic females, with a focus on timed artificial insemination (TAI). Zebu cattle, the predominant herd in Brazil, have different estrous cycle characteristics than taurine breeds, requiring different synchronization hormonal strategies for each subspecies. Estradiol combined with progesterone (P4) and prostaglandin F2 alpha (PGF) is the most used hormonal scheme for estrous cycle manipulation in TAI protocols. But the use of GnRH instead of estradiol esters is being considered. Collectively, our group's data reinforce the need to customize approaches to estrous cycle control according to the genetic composition of bovine females.(AU)
Assuntos
Animais , Feminino , Ovulação/fisiologia , Ações Farmacológicas , Ciclo Estral/efeitos dos fármacos , Progesterona , Inseminação Artificial/métodosResumo
Abstract This study aimed to evaluate the effect of synchronization with prostaglandin F2α in Baixadeiro mares during the rainy and dry seasons. Fourteen mares were synchronized by administering two doses of 1 mL prostaglandin PGF 2α and monitored by rectal palpation and ultrasound for the assessment of follicular development and uterine echotexture. Of this total, nine mares allowed the collection of blood, in which the blood was collected by venipuncture of the jugular vein to determine progesterone (P4) by ELISA. Mares showed no differences (P > 0.05) in weight, body score condition (BSC), tone, uterine edema, frequency of ovulation, synchronization interval, estrus, and the total number of follicles between periods. However, there was a difference in large increased follicle diameter (P < 0.05) during the dry season. The average concentrations of P4 in mares differed (P < 0.05) between the pre- and post-ovulatory phases for both seasons and after ovulation, with higher concentrations in the rainy season. Furthermore, statistical differences in daily light (P < 0.05) were observed between the dry and rainy periods. Thus, we conclude that mares from the genetic grouping Baixadeiro showed no reproductive seasonality, though there was a difference in luminosity between the rainy and dry seasons. The treatment with two doses of PGF 2α was effective in synchronizing the mares, promoting the return of estrus in the dry and rainy periods. The mares remaining cyclically active throughout the year provided there were appropriate forage availability and quality levels to allow for normal values of body weight and condition.
Resumo
Although studies have shown positive effects of gonadotropin releasing hormone (GnRH) or prostaglandin F2α (PGF2α) at the moment of fixed-time artificial insemination (FTAI) in the conception rate (CR) of cattle, its effects on treatments based on progesterone (P4) and estradiol benzoate (EB) is still not conclusive. The objective of this study was (1) to evaluate the effect of a PGF2α analogue at FTAI in the CR of crossbred beef cows submitted to a 11d FTAI protocol based on P4 and EB; and (2) to describe the CR between PGF2α-treated and control cows in different body condition scores (BCS) and parity categories. Crossbred (½ Nellore and ½ Angus) beef cows were submitted to a synchronization protocol and randomly assigned into 2 groups: Control (n = 163), at FTAI cows received 2 mL of saline solution as a placebo, and PGF2α (n = 163), at FTAI cows were treated with PGF2α analogue (10 mg of dinoprost tromethamine). Pregnancy diagnosis was performed 33d post-FTAI. Binary logistic regression model was used to analyze the effect of PGF2α treatment on CR. There was no difference in CR between PGF2α and control groups (P > 0.05; odds ratio (OR) = 0.92; confidence interval (CI) = 0.59-1.4). A greater CR was found in heifers (P = 0.0006, OR = 2.65, CI = 1.61 - 4.38) and multiparous (P = 0.0006, OR = 2.12, CI = 1.04 - 4.3) when compared to primiparous cows. Cows with low BCS (4; 9-point scale) showed lower CR when compared with moderate BCS (5-6; 9-point scale) (P < 0.05; OR = 0.10; CI = 0.06 - 0.18). There was no numerical difference on CR between PGF2α-treated and control cows in different BCS and parity categories. The results suggested that the CR in this study was not influenced by 10 mg PGF2α analogue at FTAI.(AU)
Assuntos
Animais , Feminino , Bovinos/fisiologia , Inseminação Artificial/veterinária , Dinoprosta/uso terapêutico , Modelos LogísticosResumo
This study aimed to evaluate the effect of synchronization with prostaglandin F2α in Baixadeiro mares during the rainy and dry seasons. Fourteen mares were synchronized by administering two doses of 1 mL prostaglandin PGF 2α and monitored by rectal palpation and ultrasound for the assessment of follicular development and uterine echotexture. Of this total, nine mares allowed the collection of blood, in which the blood was collected by venipuncture of the jugular vein to determine progesterone (P4) by ELISA. Mares showed no differences (P > 0.05) in weight, body score condition (BSC), tone, uterine edema, frequency of ovulation, synchronization interval, estrus, and the total number of follicles between periods. However, there was a difference in large increased follicle diameter (P < 0.05) during the dry season. The average concentrations of P4 in mares differed (P < 0.05) between the pre- and post-ovulatory phases for both seasons and after ovulation, with higher concentrations in the rainy season. Furthermore, statistical differences in daily light (P < 0.05) were observed between the dry and rainy periods. Thus, we conclude that mares from the genetic grouping Baixadeiro showed no reproductive seasonality, though there was a difference in luminosity between the rainy and dry seasons. The treatment with two doses of PGF 2α was effective in synchronizing the mares, promoting the return of estrus in the dry and rainy periods. The mares remaining cyclically active throughout the year provided there were appropriate forage availability and quality levels to allow for normal values of body weight and condition.
Assuntos
Feminino , Animais , Cavalos/fisiologia , Folículo Ovariano , Prostaglandinas , Sincronização do EstroResumo
This study aimed to evaluate the effect of synchronization with prostaglandin F2α in Baixadeiro mares during the rainy and dry seasons. Fourteen mares were synchronized by administering two doses of 1 mL prostaglandin PGF 2α and monitored by rectal palpation and ultrasound for the assessment of follicular development and uterine echotexture. Of this total, nine mares allowed the collection of blood, in which the blood was collected by venipuncture of the jugular vein to determine progesterone (P4) by ELISA. Mares showed no differences (P > 0.05) in weight, body score condition (BSC), tone, uterine edema, frequency of ovulation, synchronization interval, estrus, and the total number of follicles between periods. However, there was a difference in large increased follicle diameter (P < 0.05) during the dry season. The average concentrations of P4 in mares differed (P < 0.05) between the pre- and post-ovulatory phases for both seasons and after ovulation, with higher concentrations in the rainy season. Furthermore, statistical differences in daily light (P < 0.05) were observed between the dry and rainy periods. Thus, we conclude that mares from the genetic grouping Baixadeiro showed no reproductive seasonality, though there was a difference in luminosity between the rainy and dry seasons. The treatment with two doses of PGF 2α was effective in synchronizing the mares, promoting the return of estrus in the dry and rainy periods. The mares remaining cyclically active throughout the year provided there were appropriate forage availability and quality levels to allow for normal values of body weight and condition.(AU)
Assuntos
Animais , Feminino , Cavalos/fisiologia , Folículo Ovariano , Sincronização do Estro , ProstaglandinasResumo
O controle da função luteal é realizado por um balanço de fatores luteotróficos e luteolíticos, e nenhuma luteolisina de origem uterina está envolvida na regulação do corpo lúteo cíclico canino. Todavia, ao final da gestação, um pico de PGFM reflete a síntese e secreção de PGF2α envolvida na luteólise pré-parto. Em cadelas, a prolactina e o LH, mas também a PGE2, P4 e E2, e possivelmente citocinas e fatores de crescimento agem como fatores autócrinos e parácrinos para regular a função luteal. O hipoluteoidismo é definido como uma diminuição precoce da secreção de progesterona, com concentração insuficiente para a manutenção da gestação, causando perdas gestacionais. Entretanto, o valor de corte da concentração de progesterona para o diagnóstico ainda é controverso. A suplementação exógena com progestágenos é eficaz em manter a gestação, mas nas fases iniciais da gestação pode causar efeitos teratogênicos nos fetos.(AU)
El control de la función lútea se lleva a cabo por un equilibrio de factores luteotróficos y luteolíticos, y ninguna luteolisina de origen uterino está involucrada en la regulación del cuerpo lúteo cíclico canino. Sin embargo, al final del embarazo, un pico de PGFM refleja la síntesis y secreción de PGF2α involucrada en la luteólisis anteparto. En las perras, la prolactina y la LH, pero también la relaxina, PGE2, la P4 y la E2, y posiblemente citoquinas y factores de crecimiento, actúan como factores autocrinos y paracrinos para regular la función lútea. El hipoluteismo se define como una disminución precoz de la secreción de progesterona, con una concentración insuficiente para el mantenimiento del embarazo, provocando pérdidas gestacionales. Sin embargo, el valor de corte de la concentración de progesterona para el diagnóstico sigue siendo controvertido. La suplementación exógena con progestágenos es eficaz para mantener el embarazo, pero puede causar efectos teratogénicos en los fetos.(AU)
Assuntos
Animais , Feminino , Cães/fisiologia , Fase Luteal/fisiologia , Dinoprosta/análise , Hormônios do Corpo Lúteo , Luteolíticos/análiseResumo
Purpose: To investigate the mechanism of polysaccharides from aloe vera (PAV), a main active ingredient of Aloe vera, treatment in pulpitis rats. Methods: Pulpitis were modeled by drilling the occlusal central fossa with Sprague Dawley rats. Next, the rats were treated with 20, 40, and 80 mg/kg PAV for three weeks, respectively. Computed tomography scanning assay, hematoxylin and eosin staining, and tartrate-resistant acid phosphatase staining were used to detect the pathology change. Then, levels of tumor necrosis factor-α, interleukin-1ß, prostaglandin E2, and ciclooxigenase 2 were detected by enzyme-linked immunosorbent assay. The expressions of bone morphogenetic protein 2 human (BMP-2), osteocalcin, osterix, and runt-related transcription factor 2 (Runx2) were quantified by quantitative real-time polymerase chain reaction and Western blotting (WB). Finally, Wnt3a expression, p-GSK3ß/GSK3ß and p-ß-catenin/ß-catenin ratio were analyzed by WB. Results: PAV up regulated the bone mineral density, and reduced the breakage of the crown and cervical structures, and the necrosis of the crown and root pulp of pulpitis rats. In addition, results indicated that PAV could inhibit osteoblast formation. While osteoblasts' number was decreased, proteins of BMP-2, osteocalcin, osterix, and Runx2 were up-regulated by PAV. Furthermore, PAV increased the Wnt3a expression and the p-ß-catenin/ß-catenin ratio, and decreased p-GSK3ß/GSK3ß ratio. Interestingly, these effects were all in dose dependence. Conclusions: PAV could inhibit pulp inflammation and promote osteoblasts differentiation via suppressing the activation of the Wnt/ß-catenin signaling, enhancing the dental bone density.
Assuntos
Animais , Ratos , Osteoblastos , Polissacarídeos/uso terapêutico , Pulpite , Aloe , Animais de LaboratórioResumo
Purpose: To investigate the effect of givinostat treatment in acetic acid-induced ulcerative colitis model in rats. Methods: Thirty male Wistar albino rats were used. Rats were randomly divided into three equal groups, and colitis was induced on 20 rats by rectal administration of %4 solutions of acetic acid. Twenty rats with colitis were randomly divided into two groups. %0.9 NaCl (saline) solution was administered intraperitoneally to the first group of rats (saline group, n=10) at the dose of 1 mL/kg/day. Givinostat was administered intraperitoneally to the second group rats (Givinostat group, n=10) at the dose of 5 mg/kg/day. Samples were collected for biochemical analysis. Colon was removed for histopathological and biochemical examinations. Results: Plasma tumor necrosis factor-α (TNF-α), pentraxin-3 (PTX-3), and malondialdehyde levels were significantly decreased in the givinostat group compared to the saline group (p<0.05, p<0.001, and p<0.001 respectively; p<0.001, p<0.001, and p<0.001, respectively). Colon TNF-α and prostaglandin F2 alpha (PGF-2) levels were significantly decreased (p<0.05, and p<0.001, respectively). The givinostat group had a significantly lower histologic score than saline group (p<0.001, and p<0.001, respectively). Conclusions: Givinostat, a good protector and regenerator of tissue and an anti-inflammatory agent, may be involved in the treatment of colitis in the future.
Assuntos
Animais , Ratos , Regeneração , Terapêutica , Colite Ulcerativa , Anti-InflamatóriosResumo
Management of calves and heifers directly influence the future productivity of dairy animals. However, the pre-production stage is often neglected by farmers, as young cows do not yet produce milk and, therefore, revenue, while representing an important part of the total cost of the property. This study aimed to identify and determine the economic value of factors influencing the production in the first lactation of heifers in a herd. This was a case study carried out on a family property in the municipality of Patrocínio, state of Minas Gerais, using data from 54 heifers. Qualitative characteristics (sire, maternal grandsire, amount of colostrum consumed, antibiotics use on the first day of life; application of prostaglandin to induce estrus, application of prostaglandin for resynchronization, use of progesterone implant for resynchronization, occurrence of retention of placenta and/or abortion, induction of lactation) and quantitative characteristics (weight at 90 days, average daily gain at 90 days and age at first mating) were evaluated. Variables influencing the production in the first lactation were the application of antibiotics, retained placenta, induction of lactation and age at mating. The differences in milk revenue were -R$ 2,381.21 for the use of antibiotics in each female, -R$ 299.85 for each heat loss for the first mating, -R$ 5,043.11 for each lactation induction, -R$6,841.16 for each retained placenta with abortion and - R$1,060.96 for each case of retained placenta without abortion. Knowing the productive and economic consequences of each of these items provides the producer with subsidies for decision making, such as planning management strategies that avoid such losses, and choosing options to maximize the economic efficiency of production.
O manejo e os cuidados com as bezerras e novilhas influenciam diretamente a produtividade futura das fêmeas leiteiras. No entanto, muitas vezes a fase pré-produtiva é negligenciada pelos produtores, pois ao mesmo tempo que representam uma parcela importante do custo total da propriedade, as fêmeas jovens ainda não produzem leite e, portanto, receita. Objetivou-se identificar e determinar o valor econômico de fatores que influenciam na produção na primeira lactação de novilhas em um rebanho. O estudo de caso foi realizado em uma propriedade familiar na cidade de Patrocínio/MG, utilizando os dados de 54 novilhas. Foram avaliadas características qualitativas (pai, avô materno, quantidade de colostro consumida, uso de antibiótico no primeiro dia de vida; aplicação de prostaglandina para indução do cio, aplicação de prostaglandina para ressincronização, uso de implante de progesterona para ressincronização, ocorrência de retenção de placenta e/ou aborto, indução de lactação) e quantitativas (peso aos 90 dias, ganho médio diário aos 90 dias e idade à primeira cobertura). As variáveis que influenciaram a produção na primeira lactação foram a aplicação de antibióticos, retenção de placenta, indução à lactação e idade cobertura. As diferenças na receita do leite foram de -R$ 2.381,21 para o uso de antibióticos em cada fêmea, -R$ 299,85 para cada cio perdido para a primeira cobertura, -R$ 5.043,11 para cada indução de lactação, de -R$ 6.841,16 para cada ocorrência de retenção de placenta com aborto e de -R$ 1.060,96 para cada caso de retenção de placenta sem aborto. Conhecer as implicações produtivas e econômicas de cada um destes itens fornece ao produtor tem subsídios para tomadas de decisão, como planejar estratégias de manejo que evitem tais prejuízos, e escolher as opções que maximizem a eficiência econômica da produção.
Assuntos
Animais , Feminino , Bovinos , Lactação , Custos e Análise de Custo/economia , Indústria de Laticínios/estatística & dados numéricos , Criação de Animais Domésticos/economia , Criação de Animais Domésticos/métodos , Brasil , Tomada de DecisõesResumo
In the present study, we investigate the effect of the presence or absence of corpus luteum (CL) at the beginning of a fixed-time artificial insemination (FTAI) protocol and to evaluate the impact of one-time use of intravaginal progesterone device (P4 device) in cows with or without CL. A total of 776 primiparous Nellore cows were subjected to FTAI approximately 45 days postpartum. In Experiment 1, 476 cows were divided into two experimental groups: with (CL-present, n=113) or without (CL-absent, n=363) CL, after ultrasound evaluation. On day 0 (D0), all cows received a new P4 device (1.0 g) and 2.0 mg estradiol benzoate (EB). Eight days later (D8), the P4 devices were withdrawn, and prostaglandin (15 mg), estradiol cypionate (0.5 mg), and eCG (300 IU) were administered i.m. All cows were inseminated 48 h after P4 device withdrawal (D10). In Experiment 2, the cows (n= 300) received (at D0) P4 devices that were previously used once in other cows with (n=109) or without CL (n=191) and 2 mg of EB. The same protocol as that used in Experiment 1 was performed from D8 onwards. In Experiment 1, the overall conception rate after FTAI was 55% (262/476). No difference was found in the conception rate between CL-present and CL-absent cows (52.2 vs. 55.5%). In Experiment 2, the conception rate obtained with P4 devices previously used in cows with CL (58.7%) was greater (P<0.05) than that obtained with P4 devices previously used in cows without CL (42.9%). Thus, this strategy resulted in a 15.8% increase in conception rate. In conclusion, the presence or absence of CL at the beginning of the FTAI protocol did not affect the conception rate in cows synchronized with the new P4 device, but the insertion of P4 devices previously used in cows with CL enhanced the conception rates in cows without CL.
No presente estudo, investigamos o efeito da presença ou ausência de corpo lúteo (CL) no início de um protocolo de inseminação artificial em tempo fixo (IATF) e avaliamos o impacto do uso único de dispositivo intravaginal de progesterona (dispositivo P4) em vacas com ou sem CL. Um total de 776 vacas Nelore primíparas, aproximadamente 45 dias pós-parto foram submetidas à IATF. No Experimento 1, após avaliação ultrassonográfica, 476 vacas foram divididas em dois grupos experimentais: com (CL-presente, n=113) ou sem (CL-ausente, n=363) CL. No dia 0 (D0), todas as vacas receberam um novo dispositivo de P4 (1,0 g) e 2.0 mg de benzoato de estradiol (BE). Após 8 dias (D8), os dispositivos P4 foram retirados e prostaglandina (15 mg), cipionato de estradiol (0,5 mg) e eCG (300 UI) foram administrados i.m. Todas as vacas foram inseminadas 48 horas após a retirada do dispositivo de P4 (D10). No Experimento 2, as vacas (n= 300) receberam (no D0) um dispositivo de P4 previamente utilizado uma única vez em outras vacas com (n=109) ou sem CL (n=191) e 2 mg de BE. O mesmo protocolo utilizado no Experimento 1 foi realizado a partir do D8. No experimento 1, a taxa geral de concepção após IATF foi de 55% (262/476). Não foi encontrada diferença na taxa de concepção entre as vacas com CL presente e CL ausente (52,2 vs. 55,5%). No Experimento 2, a taxa de concepção obtida com dispositivos P4 previamente utilizados em vacas com CL-presente (58,7%) foi maior (P<0,05) quando comparada aos dispositivos P4 previamente utilizados em vacas com CL-ausente (42,9%). Essa estratégia resultou em aumento de 15,8% na taxa de concepção. Em conclusão, a presença ou ausência de CL no início do protocolo de IATF não afetou a taxa de concepção em vacas sincronizadas com dispositivo novo de P4; e a eficácia dos dispositivos de P4 previamente utilizados em vacas com CL é maior durante seu segundo uso em vacas sem CL.
Assuntos
Animais , Bovinos , Progesterona , Reprodução , Gravidez , Corpo LúteoResumo
A IATF é uma biotecnologia da reprodução que permite o melhoramento genético dos rebanhos de corte, pois possibilita a sincronização da ovulação e realização da inseminação artificial sem necessidade de detecção do cio. O objetivo deste estudo, foi avaliar a eficiência da pré-sincronização com a utilização prévia de progesterona (P4) injetável, sua influência e efeitos na taxa de prenhez, por meio da realização de um protocolo de IATF em vacas de corte multíparas, em quatro fazendaslocalizadas no Mato Grosso do Sul-SP. Para o estudo foram utilizadas 396 vacas nelores, os animais de cada fazenda foram alocados em grupos distintos experimental e controle. Foram avaliadas 196 vacas pertencentes ao grupo controle, e 200 vacas tratadas com progesterona no total, sendo as fazendas descritas neste estudo como fazenda A, B, C e D. Dez dias antes do início do protocolo (D-10), foi aplicado progesterona injetável, via intramuscular em animais do mesmo lote, no D0 foi aplicado benzoato de estradiol e colocado o dispositivo intravaginal com liberação de progesterona, além da classificação dos animais que apresentavam ou não o corpo lúteo. No D8 o dispositivo foi retirado e aplicado uma dose de gonadotrofina coriônica equina, e cipionato de estradiol e de prostaglandina. A inseminação artificial em tempo fixo foi realizada no D10, com a utilização de sêmen de touros provados. O diagnóstico de gestação foi feito no D40, comparando os resultados das taxas de prenhez das vacas dos diferentes grupos, que foram tratadas ou não com progesterona de forma prévia ao protocolo. Sobre as taxas de prenhez dos animais tratados com progesterona, foram encontrados os resultados da fazenda A= 6,60%, fazenda B=10,80%, fazenda C= 3,90% e fazenda D= 3,70%, assim ficando evidente que essa biotecnologia da reprodução é lucrativa e contribui positivamente para a cadeia de produção de bovinos de corte. Baseado nos resultados, pode-se concluir que o uso da P4 (injetável) obteve êxito no índice de prenhez.(AU)
The IATF is a reproduction biotechnology that allows the genetic improvement of beef herds,as it allows the synchronization of ovulation and artificial insemination without the need for heat detection. The objective of this study was to evaluate the efficiency of pre-synchronization with the previous use of injectable progesterone (P4), its influence and effects on the pregnancy rate, through the performance of an IATF protocol in multiparous beef cows, in four farms located in Mato Grosso do Sul-SP. For the study, 396 Nelore cows were used, the animals from each farm were allocated into different experimental and control groups. A total of 196 cows belonging to the control group were evaluated, and 200 cows treated with progesterone in total, being the farms described in this study as farms A, B, C and D. Ten days before the beginning of the protocol (D-10), injectable progesterone was administered , intramuscularly in animals of the same batch, on D0 estradiol benzoate was applied and the intravaginal device was placed with progesterone release, in addition to the classification of animals that had or did not have the corpus luteum. On D8, the device was removed and a dose of equine chorionic gonadotropin, estradiol and prostaglandin cypionate was applied.Fixed-time artificial insemination was performed on D10, using semen from proven bulls. The pregnancy diagnosis was made on D40, comparing the results of the pregnancy rates of the cows of the different groups, which were treated or not with progesterone prior to the protocol. From the pregnancy rates of animals treated with progesterone, the results were found for farm A= 6.60%, farm B= 10.80%, farm C= 3.90% and farm D= 3.70%, thus becoming evident that this reproductive biotechnology is profitable and contributes positively to the beef cattle production chain. Based on the results, it can be concluded that the use of P4 (injectable) was successful in the pregnancy rate.(AU)
La IATF es una biotecnología de la reproducción que permite la mejora genética de rebaños de carne, ya que permite sincronizar la ovulación y la inseminación artificial sin necesidad de detección de celo. El objetivo de este estudio fue evaluar la eficiencia de la presincronización con el uso previo de progesterona inyectable (P4), su influencia y efectos en la tasa de preñez, mediante la realización de un protocoloIATF en vacas de carne multíparas, en cuatro fincas ubicadas en Mato Grosso do Sul-SP. Para el estudio se utilizaron 396 vacas Nelore, los animales de cada finca se distribuyeron en diferentes grupos experimentales y de control. Se evaluaron un total de 196 vacas pertenecientes al grupo control, y 200 vacas tratadas con progesterona en total, siendo las fincas descritas en este estudio como fincas A, B, C y D. Diez días antes del inicio del protocolo (D-10), se administró progesterona inyectable, por vía intramuscular en animales del mismo lote, sobre D0 se aplicó benzoato de estradiol y se colocó el dispositivo intravaginal con liberación de progesterona, además de la clasificación de animales que tenían o no cuerpo lúteo. El D8 se retiró el dispositivo y se aplicó una dosis de gonadotropina coriónica equina, estradiol y cipionato de prostaglandina. Se realizó inseminación artificial a tiempo fijo en D10, utilizando semen de toros probados. El diagnóstico de preñez se realizó el D40, comparando los resultados de las tasas de preñez de las vacas de los diferentes grupos, que fueron tratadas o no con progesterona previo al protocolo. A partir de las tasas de preñez de los animales tratados con progesterona se encontraron los resultados para la finca A= 6.60%, finca B= 10.80%, finca C= 3.90% y finca D= 3.70%, evidenciándose así que esta biotecnología reproductiva es rentable y contribuye positivamente a la cadena productiva del ganado vacuno de carne. Con base en los resultados, se puede concluir que el uso de P4 (inyectable) fue exitoso en la tasa de embarazo.(AU)
Assuntos
Animais , Feminino , Progesterona/efeitos adversos , Bovinos , Biotecnologia/métodos , Brasil , Prenhez , Inseminação Artificial/métodosResumo
This study aimed to evaluate the role of prostaglandin F2α (PGF) on ovulation. In Experiment 1, cows were randomly allocated to two treatments to receive 150 µg of d-Cloprostenol (PGF Group, n = 12) or 2 mL of NaCl 0.9% (Control Group, n = 11) and CIDRsï, were removed 4 days later. No cow ovulated in Control and PGF groups. In Experiment 2, cows were randomly separated into two experimental groups to receive 4 injections of 150 µg of d-Cloprostenol (n = 9) or 2 mL of NaCL 0.9% (n = 9). In this experiment, ovulation was not observed in any cows. In Experiment 3, ovariectomized cows receive three injections of 300µg of PGF analog (PGF Group, n = 5), 100µg of Lecirelin (GnRH Group, n = 5) or 2 mL of PBS (Control Group, n = 4). The LH concentration was higher (P <0.0001) in cows from the GnRH group than in the PGF and Control groups. In experiment 4, cows with preovulatory follicles (>11.5 mm) were treated with Saline (Control Group, n = 6); Lecirelin (GnRH Group, n = 7) or Cloprostenol Sodium (PGF Group, n = 6). There was a significant increase in the vascular area of follicles from 0 to 24 h in GnRH and PGF treatments. In conclusion, PGF was not able to induce ovulation in cows with high or low plasma progesterone concentration. Additionally, PGF alone was not able to induce LH release and follicle luteinization, but increased follicular vascularization.(AU)
O objetivo deste estudo foi avaliar o papel da prostaglandina F2α (PGF) na ovulação. No Experimento 1, as vacas foram alocadas aleatoriamente em dois tratamentos para receber 150 µg de d-Cloprostenol (Grupo PGF, n = 12) ou 2 mL de NaCl 0,9% (Grupo Controle, n = 11) e os CIDRï, foram removidos 4 dias depois. Nenhuma vaca ovulou nos grupos Controle e PGF. No Experimento 2, as vacas foram separadas aleatoriamente em dois grupos experimentais para receber 4 injeções de 150 µg de d-Cloprostenol (n = 9) ou 2 mL de NaCL 0,9% (n = 9). Não foi observada ovulação em nenhum dos animais deste experimento. No Experimento 3, vacas ovariectomizadas receberam três injeções de 300µg de análogo de PGF (Grupo PGF, n = 5), 100µg de Lecirelina (Grupo GnRH, n = 5) ou 2 mL de PBS (Grupo Controle, n = 4). A concentração de LH foi maior (P <0,0001) nas vacas do grupo GnRH do que nos grupos PGF e Controle. No Experimento 4, vacas com folículos pré-ovulatórios (> 11,5 mm) foram tratadas com solução salina (Grupo Controle, n = 6), Lecirelina (Grupo GnRH, n = 7) ou Cloprostenol Sódico (Grupo PGF, n = 6). Houve um aumento significativo na área vascular dos folículos de 0 a 24h nos tratamentos com GnRH e PGF. Em conclusão, a PGF não foi capaz de induzir ovulação em vacas com alta ou baixa concentração plasmática de progesterona. Além disso, a PGF sozinha não foi capaz de induzir a liberação de LH e a luteinização do folículo, mas aumentou a vascularização folicular.(AU)